Page last updated: 2024-08-16

salmeterol xinafoate and Altitude Hypoxia

salmeterol xinafoate has been researched along with Altitude Hypoxia in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (77.78)	29.6817
2010's	2 (22.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bultas, J	1
Chandramoorthi, GD; Marimuthu, P; Piramanayagam, S	1
Auerbach, PS; Grissom, CK; Hackett, PH; Luks, AM; McIntosh, SE; Rodway, GW; Schoene, RB; Zafren, K	1
Cruden, NL; Newby, DE; Webb, DJ	1
Bärtsch, P; Mairbäurl, H	1
Pandit, A	1
Fagenholz, PJ; Gutman, JA; Harris, NS; Murray, AF	1
Voelkel, NF	1
Allemann, Y; Cook, S; Duplain, H; Egli, M; Hugli, O; Hutter, D; Lepori, M; Lipp, E; Nicod, P; Sartori, C; Scherrer, U; Turini, P	1

Trials

1 trial(s) available for salmeterol xinafoate and Altitude Hypoxia

Article	Year
Salmeterol for the prevention of high-altitude pulmonary edema. The New England journal of medicine, 2002, May-23, Volume: 346, Issue:21 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Altitude Sickness; Biological Transport, Active; Double-Blind Method; Epithelium; Female; Humans; Hypertension, Pulmonary; Hypoxia; Male; Membrane Potentials; Middle Aged; Nasal Mucosa; Pulmonary Alveoli; Pulmonary Edema; Salmeterol Xinafoate; Sodium	2002

Article

Year

Salmeterol for the prevention of high-altitude pulmonary edema.

The New England journal of medicine, 2002, May-23, Volume: 346, Issue:21

Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Altitude Sickness; Biological Transport, Active; Double-Blind Method; Epithelium; Female; Humans; Hypertension, Pulmonary; Hypoxia; Male; Membrane Potentials; Middle Aged; Nasal Mucosa; Pulmonary Alveoli; Pulmonary Edema; Salmeterol Xinafoate; Sodium

2002

Other Studies

8 other study(ies) available for salmeterol xinafoate and Altitude Hypoxia

Article	Year
[Mountain sickness]. Casopis lekaru ceskych, 2015, Volume: 154, Issue:6 Topics: Acetazolamide; Acute Disease; Adaptation, Physiological; Altitude; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Combined Modality Therapy; Dexamethasone; Humans; Hypertension, Pulmonary; Oxygen; Oxygen Inhalation Therapy; Salmeterol Xinafoate	2015
An insilico approach to high altitude pulmonary edema - Molecular modeling of human beta2 adrenergic receptor and its interaction with Salmeterol & Nifedipine. Journal of molecular modeling, 2008, Volume: 14, Issue:9 Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Altitude Sickness; Amino Acid Sequence; Binding Sites; Bronchodilator Agents; Computer Simulation; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Molecular Structure; Molecular Weight; Nifedipine; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Pulmonary Edema; Receptors, Adrenergic, beta-2; Reproducibility of Results; Salmeterol Xinafoate; Sequence Homology, Amino Acid; Spectrum Analysis, Raman; Vasodilator Agents	2008
Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness & environmental medicine, 2010, Volume: 21, Issue:2 Topics: Acetazolamide; Acute Disease; Albuterol; Altitude Sickness; Brain Edema; Carbolines; Dexamethasone; Humans; Mountaineering; Nifedipine; Piperazines; Pulmonary Edema; Purines; Salmeterol Xinafoate; Sildenafil Citrate; Societies; Sulfones; Tadalafil; Wilderness Medicine	2010
Salmeterol for the prevention of high-altitude pulmonary edema. The New England journal of medicine, 2002, Oct-17, Volume: 347, Issue:16 Topics: Albuterol; Altitude Sickness; Biological Transport, Active; Epithelium; Hemodynamics; Humans; Nitric Oxide; Pulmonary Alveoli; Pulmonary Edema; Salmeterol Xinafoate; Sodium	2002
Salmeterol for the prevention of high-altitude pulmonary edema. The New England journal of medicine, 2002, Oct-17, Volume: 347, Issue:16 Topics: Adrenergic beta-Agonists; Albuterol; Altitude Sickness; Blood Pressure; Bronchodilator Agents; Echocardiography, Doppler; Humans; Pulmonary Alveoli; Pulmonary Artery; Pulmonary Edema; Salmeterol Xinafoate; Sodium	2002
The physiologic basis of high-altitude diseases. Annals of internal medicine, 2005, Apr-05, Volume: 142, Issue:7 Topics: Adrenergic beta-Agonists; Albuterol; Altitude Sickness; Animals; Extravascular Lung Water; Humans; Pulmonary Edema; Salmeterol Xinafoate	2005
Treatment of high altitude pulmonary edema at 4240 m in Nepal. High altitude medicine & biology, 2007,Summer, Volume: 8, Issue:2 Topics: Acetazolamide; Adult; Albuterol; Altitude; Altitude Sickness; Bed Rest; Emergency Treatment; Female; Humans; Male; Middle Aged; Mountaineering; Nepal; Nifedipine; Oxygen Inhalation Therapy; Piperazines; Pulmonary Edema; Purines; Salmeterol Xinafoate; Sildenafil Citrate; Sulfones; Treatment Outcome; Vasodilator Agents	2007
High-altitude pulmonary edema. The New England journal of medicine, 2002, May-23, Volume: 346, Issue:21 Topics: Adrenergic beta-Agonists; Albuterol; Altitude Sickness; Biological Transport, Active; Epithelium; Humans; Membrane Potentials; Pulmonary Alveoli; Pulmonary Edema; Salmeterol Xinafoate; Sodium	2002